CATALENT, INC., also called Catalent, is a holding company, which engages in the provision of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. It operates through the following segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. Read More The Softgel Technologies segment focuses on the formulation, development, and manufacture of prescription and consumer health soft capsules, softgels, vegicaps and optishell capsules. The Biologics and Specialty Drug Delivery segment researches and develop biologic drug products in prefilled syringes, vials, cartridges, blow-fill-seal unit doses, and injectable formats. The Oral Drug Delivery segment offers formulates oral dosage forms. The Clinical Supply Services segment includes the packaging, labeling, storage, distribution, and inventory management of patient kits for clinical trials of drugs. It also provides clinical e-solutions and informatics, and global comparator sourcing services. The company was founded in April 2007 and is headquartered in Somerset, NJ.